ACM
DXCM icon

Advent Capital Management’s DexCom DXCM Stock Holding History

Advent Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-40,000
Closed -$3.49M – 232
2025
Q2 		$3.49M Sell
40,000
-10,000
-20% -$784K 0.07% 154
2025
Q1 		$3.41M Buy
+50,000
New +$4.08M 0.07% 143
2024
Q4 		– Sell
-2,605
Closed -$175K – 221
2024
Q3 		$175K Buy
+2,605
New +$214K ﹤0.01% 214
2021
Q2 		– Sell
-48
Closed -$4K – 266
2021
Q1 		$4K Buy
+48
New +$4.51K ﹤0.01% 242

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Advent Capital Management's DXCM Position: Q3 2025 in Review

Advent Capital Management sold out of DexCom (DXCM) in Q3 2025, closing a stake of 40,000 shares — an estimated $3.49M sold.

Advent Capital Management first reported a position in DXCM in Q1 2021 and held it in 4 quarters. The position peaked at $3.49M in Q2 2025. 911 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.

  • Advent Capital Management reported no remaining DexCom position as of Q3 2025 after selling out during the quarter.
  • Advent Capital Management sold 40,000 DexCom shares in Q3 2025, an estimated $3.49M.
  • Advent Capital Management first reported a position in DexCom in Q1 2021 and held it in 4 quarters.
  • Advent Capital Management's DexCom position peaked at $3.49M in Q2 2025.
  • 911 funds tracked by Wall St. Rank held DexCom as of Q3 2025.

Based on Advent Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.